MIM MONDO IGEL MEDIA AG |
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| Jun. 06 | Medios at two-month high after buy recommendation | DP |
| Jun. 06 | Medios AG acquired Ceban B.V. from Bencis Capital Partners B.V. | CI |
| Sales 2024 * | 2.02B 2.17B | Sales 2025 * | 2.18B 2.34B | Capitalization | 385M 414M |
|---|---|---|---|---|---|
| Net income 2024 * | 28M 30.09M | Net income 2025 * | 43M 46.21M | EV / Sales 2024 * | 0.27 x |
| Net Debt 2024 * | 156M 168M | Net Debt 2025 * | 117M 125M | EV / Sales 2025 * | 0.23 x |
| P/E ratio 2024 * |
14.2
x | P/E ratio 2025 * |
10.5
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99% |
More Fundamentals
* Assessed data
More news
Latest transcript on MIM MONDO IGEL MEDIA AG
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 14-11-05 | |
Falk Neukirch
DFI | Director of Finance/CFO | 53 | 21-09-30 |
Mi Young Miehler
COO | Chief Operating Officer | 55 | 17-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yann Samson
CHM | Chairman | 51 | 14-11-06 |
Klaus Buß
BRD | Director/Board Member | 62 | 16-09-13 |
Joachim Messner
BRD | Director/Board Member | 63 | 16-09-13 |
Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.
Sector
Pharmaceuticals
Calendar
2024-08-12
- Q2 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +49.42% | 779B | |
| +40.67% | 631B | |
| -6.19% | 354B | |
| +20.95% | 333B | |
| +8.66% | 301B | |
| +16.75% | 249B | |
| -1.19% | 216B | |
| +10.85% | 214B | |
| +4.64% | 163B |
- Stock Market
- Equities
- ILM1 Stock
- ILM Stock
